Role of PACAP in Migraine Headaches

Creators: Millichap, J. Gordon; Millichap, John J.

Abstract

Investigators at Danish Headache Centre, University of Copenhagen, Glostrup, Denmark, studied the incidence of migraine during and after intravenous infusion of pituitary adenylate cyclase-activating polypeptide-38 (PACAP38) and vasoactive intestinal polypeptide (VIP) in 22 female migraine patients without aura (mean age 24 years [range 19-36]).

Files

PNB-2014-28-4-3.pdf

Files (104.7 kB)

Name	Size	Download all
PNB-2014-28-4-3.pdf md5:21f8109277ae540a175805eab071a126	104.7 kB	Preview Download

Additional details